Serial studies of auditory neurotoxicity in patients receiving deferoxamine therapy.
Schindléry
C
C
Macarol
V
V
D001304:Auditory Diseases, Central / Q000139:chemically induced*; D003676:Deferoxamine / Q000008:administration & dosage*; D005293:Ferritins / Q000097:blood; D006801:Humans
D005293:Ferritins; D003676:Deferoxamine